Stereodivergent Synthesis of C -Glycosides from Glycals by Ni-Catalyzed Cross-Hydrocarbonylation of Alkenes
Journal of the American Chemical Society · 21.10.2026 · 148 (41) · 44639-44648
DOI: 10.1021/jacs.6c13660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 08.10.2026. Verfasst von Cheng-Tao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemistry and Utilization of Carbon Based Energy Resources, College of Chemistry, Xinjiang University, Urumqi830017Xinjiang, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Government of Xinjiang Uygur Autonomous Region of China, National University of Singapore, National Natural Science Foundation of China.
Abstract (Originalsprache)
C-Glycosides always significantly improve the physicochemical properties and pharmacokinetic characteristics of the native O- and N-glycosides and are one of the most powerful strategies for carbohydrate-based drug discovery. However, direct access to C-glycosides with control of stereochemistry from readily available, bench-stable, and cost-effective starting materials remains a formidable challenge. Herein, a Ni-catalyzed chemo- and regioselective iterative hydrocarbonylation of glycals with alkenes for the synthesis of stereodivergent C-acylated glycosides has been developed, representing the first example of synthesizing C-acylated glycosides from glycals. The reaction tolerates a wide range of glycals and unactivated alkenes, affording corresponding C-glycosides with diverse substitution patterns. Moreover, cross-carbonylation of primary–secondary and more sterically hindered secondary–secondary alkyl metallic intermediates was achieved, providing access to 2-deoxygenated C-glycosides from glycals without using any glycosyl electrophiles or alkyl electrophiles. Notably, both α- and β-anomers could be easily obtained with high diastereoselectivity, rendering this protocol useful for the synthesis of C-glycosides using alkenes as the sole coupling precursors.
Autor:innen und Institutionen
- State Key Laboratory of Chemistry and Utilization of Carbon Based Energy Resources, College of Chemistry, Xinjiang University, Urumqi830017Xinjiang, P. R. China.
- Shenzhen Grubbs Institute, Guangming Advanced Research Institute, Department of Chemistry, and Guangdong Provincial Key Laboratory of Catalysis, Southern University of Science and Technology, Shenzhen518055Guangdong, P.…
- College of Chemistry and Molecular Sciences, Henan University, Kaifeng475004, China.
ORCID-Profile: Keyume Ablajan, Zhong-Yan Cao, Wei Shu
Förderung
- Government of Xinjiang Uygur Autonomous Region of China
- National University of Singapore
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Southern University of Science and Technology
- Natural Science Foundation of Sichuan Province
- Guangdong Provincial Key Laboratory Of Catalysis
Zitieren
APA
Wang, C. T., Xia, Y. L., Wei, X. F., Lin, J. N., Yu, Q., Ablajan, K., Cao, Z. Y., & Shu, W. (2026). Stereodivergent Synthesis of C -Glycosides from Glycals by Ni-Catalyzed Cross-Hydrocarbonylation of Alkenes. Journal of the American Chemical Society, 148(41), 44639-44648. https://doi.org/10.1021/jacs.6c13660
Vancouver
Wang CT, Xia YL, Wei XF, Lin JN, Yu Q, Ablajan K, et al. Stereodivergent Synthesis of C -Glycosides from Glycals by Ni-Catalyzed Cross-Hydrocarbonylation of Alkenes. Journal of the American Chemical Society. 2026;148(41):44639-44648. doi:10.1021/jacs.6c13660
BibTeX
@article{Wang2026,
author = {Wang, Cheng-Tao and Xia, Yun-Long and Wei, Xing-Fu and Lin, Jia-Ni and Yu, Qiong and Ablajan, Keyume and Cao, Zhong-Yan and Shu, Wei},
title = {Stereodivergent Synthesis of C -Glycosides from Glycals by Ni-Catalyzed Cross-Hydrocarbonylation of Alkenes},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {41},
pages = {44639--44648},
doi = {10.1021/jacs.6c13660}
}
EUVIMED